Report on re-lodgment of requests for transfer of Physical shares
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals has submitted a routine compliance update to BSE regarding the re-lodgment of physical share transfer requests under SEBI's Special Window Circular dated July 2, 2025. The company's Registrar & Transfer Agent, Venture Capital and Corporate Investments Private Limited, reported the status as of December 5, 2025. The data shows zero requests were received, processed, approved, or rejected during the month. The report is a procedural filing required under the SEBI circular and contains no transfer activity to report.
This is a routine, administrative filing with no material impact on shareholders or the stock price. The nil activity simply means no shareholders sought to re-lodge pending physical share transfer requests during the reporting period.